These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 3556201

  • 1. Synthesis of enkephalinase B inhibitors, and their activity on isolated enkephalin-degrading enzymes.
    Van Amsterdam JG, Van Buuren KJ, Blad MW, Soudijn W.
    Eur J Pharmacol; 1987 Mar 31; 135(3):411-8. PubMed ID: 3556201
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Protection of enkephalins from enzymatic degradation utilizing selective metal-chelating inhibitors.
    Altstein M, Bachar E, Vogel Z, Blumberg S.
    Eur J Pharmacol; 1983 Aug 05; 91(4):353-61. PubMed ID: 6352283
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Selective protection of methionine enkephalin released from brain slices by enkephalinase inhibition.
    Patey G, De La Baume S, Schwartz JC, Gros C, Roques B, Fournie-Zaluski MC, Soroca-Lucas E.
    Science; 1981 Jun 05; 212(4499):1153-5. PubMed ID: 7015510
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Composite effects of actinonin when inhibiting enkephalin-degrading enzymes.
    Hachisu M, Hiranuma T, Shibazaki Y, Uotani K, Murata S, Aoyagi T, Umezawa H.
    Eur J Pharmacol; 1987 May 07; 137(1):59-65. PubMed ID: 2886348
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Analgesic effect of actinonin, a new potent inhibitor of multiple enkephalin degrading enzymes.
    Hachisu M, Hiranuma T, Murata S, Aoyagi T, Umezawa H.
    Life Sci; 1987 Jul 13; 41(2):235-40. PubMed ID: 3298909
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Enkephalinase inhibitors and molecular study of the differences between active sites of enkephalinase and angiotensin-converting enzyme].
    Roques BP.
    J Pharmacol; 1985 Jul 13; 16 Suppl 1():5-31. PubMed ID: 2993752
    [Abstract] [Full Text] [Related]

  • 17. Complete differentiation between enkephalinase and angiotensin-converting enzyme inhibition by retro-thiorphan.
    Roques BP, Lucas-Soroca E, Chaillet P, Costentin J, Fournié-Zaluski MC.
    Proc Natl Acad Sci U S A; 1983 Jun 13; 80(11):3178-82. PubMed ID: 6304695
    [Abstract] [Full Text] [Related]

  • 18. Effect of various enkephalin analogs and dipeptides on the enzymatic activity of enkephalinase B isolated from calf-brain striatum.
    van Amsterdam JG, van Buuren KJ, Koomen AP, Soudijn W.
    Life Sci; 1986 Mar 24; 38(12):1111-8. PubMed ID: 3515091
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.